241 related articles for article (PubMed ID: 23504102)
41. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
42. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
[TBL] [Abstract][Full Text] [Related]
43. Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.
Ji B; Liu S; He X; Man VH; Xie XQ; Wang J
ACS Chem Neurosci; 2020 Apr; 11(8):1139-1158. PubMed ID: 32196303
[TBL] [Abstract][Full Text] [Related]
44. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
45. Sex differences in distribution of cannabinoid receptors (CB1 and CB2), S100A6 and CacyBP/SIP in human ageing hearts.
Piotrowska Ż; Niezgoda M; Łebkowski W; Filipek A; Domian N; Kasacka I
Biol Sex Differ; 2018 Nov; 9(1):50. PubMed ID: 30482253
[TBL] [Abstract][Full Text] [Related]
46. CB
Howlett AC; Abood ME
Adv Pharmacol; 2017; 80():169-206. PubMed ID: 28826534
[TBL] [Abstract][Full Text] [Related]
47. Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease.
Cappellano G; Uberti F; Caimmi PP; Pietronave S; Mary DA; Dianzani C; Micalizzi E; Melensi M; Boldorini R; Nicosia G; Crosio E; Chiocchetti A; Aina F; Prat M; Dianzani U; Vacca G; Ariatti C; Grossini E
Can J Cardiol; 2013 Apr; 29(4):499-509. PubMed ID: 22926037
[TBL] [Abstract][Full Text] [Related]
48. Crystal Structure of the Human Cannabinoid Receptor CB2.
Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
[TBL] [Abstract][Full Text] [Related]
49. Distribution and function of the endocannabinoid system in the rat and human bladder.
Bakali E; Elliott RA; Taylor AH; Willets J; Konje JC; Tincello DG
Int Urogynecol J; 2013 May; 24(5):855-63. PubMed ID: 23081739
[TBL] [Abstract][Full Text] [Related]
50. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
51. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
52. Cannabinoid CB
Olianas MC; Dedoni S; Onali P
Life Sci; 2021 Jul; 276():119407. PubMed ID: 33794254
[TBL] [Abstract][Full Text] [Related]
53. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
54. Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Van Sickle MD; Duncan M; Kingsley PJ; Mouihate A; Urbani P; Mackie K; Stella N; Makriyannis A; Piomelli D; Davison JS; Marnett LJ; Di Marzo V; Pittman QJ; Patel KD; Sharkey KA
Science; 2005 Oct; 310(5746):329-32. PubMed ID: 16224028
[TBL] [Abstract][Full Text] [Related]
55. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
Izzo AA; Capasso R; Aviello G; Borrelli F; Romano B; Piscitelli F; Gallo L; Capasso F; Orlando P; Di Marzo V
Br J Pharmacol; 2012 Jun; 166(4):1444-60. PubMed ID: 22300105
[TBL] [Abstract][Full Text] [Related]
57. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
[TBL] [Abstract][Full Text] [Related]
58. Characterization of the endocannabinoid system in early human pregnancy.
Helliwell RJ; Chamley LW; Blake-Palmer K; Mitchell MD; Wu J; Kearn CS; Glass M
J Clin Endocrinol Metab; 2004 Oct; 89(10):5168-74. PubMed ID: 15472222
[TBL] [Abstract][Full Text] [Related]
59. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
De Petrocellis L; Di Marzo V
J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
[TBL] [Abstract][Full Text] [Related]
60. The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake.
Valenti M; Cottone E; Martinez R; De Pedro N; Rubio M; Viveros MP; Franzoni MF; Delgado MJ; Di Marzo V
J Neurochem; 2005 Nov; 95(3):662-72. PubMed ID: 16135090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
